HEALTHSTORY 541· JUNE 29, 2026

AstraZeneca to Pay $34 Million to Settle Texas Medicaid Kickback Claims

AstraZeneca agreed to pay $34 million to settle allegations brought by the Texas attorney general that the pharmaceutical company paid kickbacks to improperly influence prescriptions covered by Texas Medicaid. The settlement resolves…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 540Two Corrections Officers Freed After Inmate Takeover at North Carolina Detention Center NEXT STORY 542 →Simplicity Group Acquires Benefit Planning, Inc. and Adds Bob Muzikowski as Partner

Keep reading

More from the desk.

15HEALTH

FDA clears Replimune's melanoma drug Tudriqev after two rejections

A cancer treatment rejected twice by federal regulators has now won approval. The Food and Drug Administration granted accelerated approval to Tudriqev, a drug made by the biotech company Replimune, for patients with advanced melanoma…

health2 MIN

53HEALTH

Seven months after launch, Aurora Therapeutics scraps its lead gene-editing program and cuts staff

Personalized CRISPR therapies, gene-editing treatments built around one patient's specific mutation rather than a disease shared by millions, just lost one of their early backers. Aurora Therapeutics has scrapped its lead program and laid…

health2 MIN

68HEALTH

California Supreme Court rules Gilead Sciences has no legal duty to fast-track a safer HIV drug

Pharmaceutical companies do not owe patients a legal duty to speed up development of a safer drug simply because a less safe version is already on the market. That concept, called a "duty to innovate," was at the center of a case brought…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk